Company / Revenue per Share
Axsome Therapeutics, Inc. Revenue per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$13.12
FY2025
5-year range
$0.00 / $13.12
FY2022-FY2025
Trend
+61.1%
vs FY2024
Sector context
#39 of 154
Health Care
What the data says
Axsome Therapeutics, Inc.'s revenue per share of $13.12 is higher than 75% of companies in the Health Care sector (FY2025). Revenue per Share has increased for 3 consecutive years, from $0.00 in FY2022 to $13.12 in FY2025.
Based on SEC 10-K filings.
13.12 in FY2025. Top quartile in the Health Care sector.
Improved from $6.22 to $13.12 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 154This company $13.12 Sector average $15.09
▼
-13.1% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 61.1% year-over-year.
- Ranks #39 out of 154 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.12 | +61.1% |
| FY2024 | $8.15 | +30.9% |
| FY2023 | $6.22 | - |
| FY2022 | $0.00 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026